KBL Merger

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch KBL Merger and buy or sell other stocks, ETFs, and their options commission-free!

About KBLM

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. 

CEO
Blair Jordan, MBA
CEOBlair Jordan, MBA
Employees
3
Employees3
Headquarters
Palo Alto, California
HeadquartersPalo Alto, California
Founded
2016
Founded2016
Employees
3
Employees3

KBLM Key Statistics

Market cap
11.31M
Market cap11.31M
Price-Earnings ratio
-0.14
Price-Earnings ratio-0.14
Dividend yield
—
Dividend yield—
Average volume
28.99K
Average volume28.99K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$17.75
52 Week high$17.75
52 Week low
$0.6578
52 Week low$0.6578
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.